Tesetaxel

DB12019InvestigationalSmall molecule

Tesetaxel has been used in trials studying the treatment of Cancer, Melanoma, Prostate Cancer, Gastric Carcinoma, and Advanced Melanoma, among others.

Mechanism: Pharmacologically active on Tubulin
Curator reviewed
Formula / weight: C₄₆H₆₀FN₃O₁₃ · 881.992 g/mol (avg)

Resolves to

Compound

UNIIUG97LO5M8YCAS333754-36-2ChEMBLCHEMBL2107787PubChem6918574

Structure

InChIKeyMODVSQKJJIBWPZ-VLLPJHQWSA-NSMILES

CN(C)C[C@@H]1O[C@H]2[C@@H](O1)[C@]1(C)CC[C@H]3OC[C@@]3(OC(C)=O)[C@H]1[C@H](OC(=O)C1=CC=CC=C1)[C@]1(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C3=C(F)C=CC=N3)C(C)=C2C1(C)C

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Tesetaxel, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account